Higher rate of death in #Keytruda trial forces #FDA to pause other #immunotherapy studies https://t.co/maru9WteZO
— The Legal Herald (@LegalHerald) September 22, 2017
from Twitter https://twitter.com/LegalHerald
The Legal Herald
Friday 22 September 2017
Higher rate of death in #Keytruda trial forces #FDA to pause other #immunotherapy studies https://t.co/maru9WteZO
from Twitter https://twitter.com/LegalHerald
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment